Plantain Extract to Target Crohn’s Disease
UK-based ingredient supplier Provexis says it is developing a plantain-derived extract that may provide support for Crohn’s disease patients during remission.
UK-based ingredient supplier Provexis says it is developing a plantain-derived extract that may provide support for Crohn’s disease patients during remission.
“The new ingredient, which comes from a fiber found in plantain, works by inhibiting the interaction between Escherichia coli bacteria often found in Crohn’s disease patients and cells lining the intestine,” the company says. “As E. coli bacteria have been found to interrupt a number of immunological interactions, their inhibition could potentially have a range of therapeutic benefits for the patient.”
The company says it is currently conducting a randomized controlled study to examine the effects of the extract in maintaining remission in Crohn’s disease patients at four centers in the UK. It says that preliminary trials in healthy humans showed no significant adverse effects on markers of gastrointestinal health over a 21-day supplementation period.
Prinova acquires Aplinova to further increase its footprint in Latin America
April 7th 2025Prinova has recently announced the acquisition of Brazilian ingredients distributor Aplinova, which is a provider of specialty ingredients for a range of market segments that include food, beverage, supplements, and personal care.
The Nutritional Outlook Podcast Episode 39: Nutritional Outlook's Ingredients to Watch in 2025
February 25th 2025In this episode, Nutritional Outlook interviews Scott Dicker, market insights director from market researcher SPINS, about ingredients and product categories nutraceutical and nutrition product manufacturers should watch in 2025.
